Its three co founders are Dr Clement Goehrs, doctor and bio-computer engineer, Dr Louis Letinier, pharmacologist and Bruno Thiao-Layel, research engineer.
They identified a major problem in the healthcare system linked to drug misuse during their medical activities.
Indeed, 10,000 to 30,000 deaths per year attributable to drug misuse and 130,000 avoidable hospitalisations recorded per year in France. An average of 5.5 medications on a prescription from a GP.
In this context, after 2 years of R&D, Synapse Medicine (from INSERM and Bordeaux University Hospital) developed its artificial intelligence platform dedicated to correct drug usage.
Ergonomic and easy to use, this virtual medication assistant aims to support healthcare professionals in their daily life without disrupting their practices. Established in Bordeaux and Silicon Valley, Synapse Medicine is supported by a team made of drug and artificial intelligence experts: doctors, data scientists and engineers who work in close partnership with key partners.
Creation of Synapse Medicine.
Partnership with the prestigious Stanford University (USA).
Presentation of Synapse Medicine at CES, Las Vegas.
Test phase in collaboration with prescribing healthcare professionals.
Participation à Microsoft Experiences 18, l’évènement de l’intelligence numérique.
First start-up specialized in AI in collaboration with University Hospital Bordeaux.
Clinical trial conducted in the Bordeaux University Hospital emergency department on the relevance of the Synapse drug interaction module.
Large-scale Synapse experiment conducted with a group of cooperatives on tens of thousands of patients.
Some great successes to come:
Start of clinical study within geriatric medicine services in University Hospital Bordeaux.
Launch of a Synapse app for the general public
Synapse Medicine is a rapidly developing start-up.
We’re recruiting very varied profiles to be part of a young and dynamic team based in the Bordeaux hyper center.